Literature DB >> 26560945

[Epidemiology of Guillain-Barré Syndrome].

Hiroo Yoshikawa1.   

Abstract

The epidemiologic features of the Guillain-Barré syndrome (GBS) have been reported from North America, England, Iceland, and Norway before 1979. The population incidence rates of GBS fulfilling the NINCDS (National Institute of Neurological and Communicative Disorders and Stroke) criteria in USA, Canada, Italy, Spain, and Sweden ranged from 0.62 cases to 2.66 cases per 100,000 person-years across all age groups, with a relative risk of 1.78 for males. GBS incidence increased by 20% for every 10-year increase in age. In Japan, the incidence of GBS was 1.15 per 100,000 person-years. Males were affected 1.5 times more frequently than females. The average age of patients with GBS was 39.1 ± 20.0 years, which is lesser than that in North America and Europe. The relative ratio of the occurrence of Fisher syndrome among patients with GBS was higher than that in other Asian countries.

Entities:  

Mesh:

Year:  2015        PMID: 26560945     DOI: 10.11477/mf.1416200300

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  3 in total

1.  Guillain-Barré syndrome in pregnancy: A conservatively managed case.

Authors:  T N M S Fernando; A M A S Ambanwala; Probhodana Ranaweera; Athula Kaluarachchi
Journal:  J Family Med Prim Care       Date:  2016 Jul-Sep

2.  The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barré syndrome.

Authors:  Hong Jiao; Huan Ren
Journal:  Drug Des Devel Ther       Date:  2018-11-06       Impact factor: 4.162

Review 3.  The Zika virus: Lurking behind the COVID-19 pandemic?

Authors:  Joseph Pergolizzi; Jo Ann LeQuang; Sumiyo Umeda-Raffa; Charles Fleischer; Joseph Pergolizzi; Claudio Pergolizzi; Robert B Raffa
Journal:  J Clin Pharm Ther       Date:  2020-11-20       Impact factor: 2.145

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.